Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹1000 | ₹100 |
Expense Ratio | 1.96 | 1.81 |
NAV | ₹34.77 | ₹100.82 |
Fund Started | 10 Jun 2020 | 31 Jul 2008 |
Fund Size | ₹1929.59 Cr | ₹4721.61 Cr |
Exit Load | Exit load of 1%, if redeemed within 3 months. | Exit load of 1%, if redeemed within 30 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 39.69% | 41.49% |
3 Year | 21.66% | 25.00% |
5 Year | - | 23.96% |
1 Year
3 Year
5 Year
Equity | 91.82% | 97.40% |
Cash | 6.64% | 2.60% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 5.85% |
Vedanta Ltd. | 3.72% |
State Bank of India | 3.50% |
Kotak Mahindra Bank Ltd. | 2.05% |
Prudent Corporate Advisory Services Ltd. | 2.03% |
NTPC Ltd. | 2.00% |
Reliance Industries Ltd. | 2.00% |
General Insurance Corporation of India | 2.00% |
Netweb Technologies India Ltd. | 1.95% |
Hindustan Aeronautics Ltd. | 1.91% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 6.21% |
ICICI Bank Ltd. | 5.26% |
State Bank of India | 4.04% |
Infosys Ltd. | 3.90% |
Larsen & Toubro Ltd. | 2.88% |
Bharti Airtel Ltd. | 2.83% |
Dr. Reddy's Laboratories Ltd. | 2.73% |
ITC Ltd. | 2.54% |
CESC Ltd. | 2.29% |
Biocon Ltd. | 2.21% |
Name | Alok Singh | Satish Ramanathan |
Start Date | 01 Dec 2021 | 01 Oct 2024 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity-related securities across various market capitalisation. | The scheme which aims to provide capital appreciation by investing primarily in equity and equity related securities of various market depending upon valuation discount or premium amongst Large / Mid & Small cap stocks, the fund will keep varying the weights to capture the value while keeping an optimum Risk / Return profile. |
Launch Date | 10 Jun 2020 | 31 Jul 2008 |
Description
Launch Date